Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

BACKGROUND: We evaluated the risk of sampling errors in specimens of biopsy size, which may be caused by heterogeneous overexpression of Her2/neu in gastric cancer (GC). PATIENTS AND METHODS: The study cohort comprised 454 gastrectomy patients with adenocarcinoma of the stomach or esophago-gastric j...

Descripción completa

Detalles Bibliográficos
Autores principales: Warneke, V. S., Behrens, H.-M., Böger, C., Becker, T., Lordick, F., Ebert, M. P. A., Röcken, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574551/
https://www.ncbi.nlm.nih.gov/pubmed/23139264
http://dx.doi.org/10.1093/annonc/mds528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574551/
https://www.ncbi.nlm.nih.gov/pubmed/23139264
http://dx.doi.org/10.1093/annonc/mds528

Ejemplares similares